1
2
3
4
5
6
7 LONG TITLE
8 General Description:
9 This bill enacts language related to the study of abuse-deterrent opioid analgesic drug
10 products.
11 Highlighted Provisions:
12 This bill:
13 ▸ defines terms; and
14 ▸ requires the Public Employees' Benefit and Insurance Program to:
15 • study the barriers to and efficacy of use of abuse-deterrent opioid analgesic drug
16 products; and
17 • report to the Business and Labor Interim Committee and the Health and Human
18 Services Interim Committee.
19 Money Appropriated in this Bill:
20 None
21 Other Special Clauses:
22 None
23 Utah Code Sections Affected:
24 ENACTS:
25 49-20-412, Utah Code Annotated 1953
26 63I-2-249, Utah Code Annotated 1953
27
28 Be it enacted by the Legislature of the state of Utah:
29 Section 1. Section 49-20-412 is enacted to read:
30 49-20-412. Study of abuse-deterrent opioid analgesic drug products.
31 (1) As used in this section:
32 (a) "Abuse-deterrent opioid analgesic drug product" means an opioid analgesic drug
33 product with labeling approved by the Food and Drug Administration indicating that the
34 product has properties that are expected to reduce abuse of the product.
35 (b) "Opioid analgesic drug product" means a product in the opioid analgesic drug class
36 that is prescribed to treat moderate to severe pain, regardless of whether the drug is combined
37 with other substances in a single product or dosage form.
38 (2) For purposes of the report required by Subsection (3), the program shall study
39 available information regarding the barriers to and the efficacy of the use of abuse-deterrent
40 opioid analgesic drug products.
41 (3) The program shall report to the Business and Labor Interim Committee and the
42 Health and Human Services Committee by no later than the respective committee's November
43 2015 interim committee regarding the study required by Subsection (2).
44 Section 2. Section 63I-2-249 is enacted to read:
45 63I-2-249. Repeal dates -- Title 49.
46 Section 49-20-412 is repealed January 1, 2016.